Exact Mass: 549.2046376000001
Exact Mass Matches: 549.2046376000001
Found 124 metabolites which its exact mass value is equals to given mass value 549.2046376000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Jadomycin B
A jadomycin that is jadomycin A in which the phenolic hydroxy group at position 12 has been converted to the corresponding 2,6-dideoxy-alpha-L-ribo-hexopyranoside, isolated from Streptomyces venezuelae. It exists as a diastereoisomeric mixture consisting of both 3aS and 3aR isomers.
Ubrogepant
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CD - Calcitonin gene-related peptide (cgrp) antagonists C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
Cys His Gln Tyr
Cys His Tyr Gln
Cys Asn Gln Trp
Cys Asn Trp Gln
Cys Gln His Tyr
Cys Gln Asn Trp
Cys Gln Trp Asn
Cys Gln Tyr His
Cys Trp Asn Gln
Cys Trp Gln Asn
Cys Tyr His Gln
Cys Tyr Gln His
Asp Glu Thr Trp
Asp Glu Trp Thr
Asp Thr Glu Trp
Asp Thr Trp Glu
Asp Trp Glu Thr
Asp Trp Thr Glu
Glu Asp Thr Trp
Glu Asp Trp Thr
Glu Glu Ser Trp
Glu Glu Trp Ser
Glu Ser Glu Trp
Glu Ser Trp Glu
Glu Thr Asp Trp
Glu Thr Trp Asp
Glu Trp Asp Thr
Glu Trp Glu Ser
Glu Trp Ser Glu
Glu Trp Thr Asp
His Cys Gln Tyr
His Cys Tyr Gln
His Gln Cys Tyr
His Gln Tyr Cys
His Tyr Cys Gln
His Tyr Gln Cys
Asn Cys Gln Trp
Asn Cys Trp Gln
Asn Gln Cys Trp
Asn Gln Trp Cys
Asn Trp Cys Gln
Asn Trp Gln Cys
Gln Cys His Tyr
Gln Cys Asn Trp
Gln Cys Trp Asn
Gln Cys Tyr His
Gln His Cys Tyr
Gln His Tyr Cys
Gln Asn Cys Trp
Gln Asn Trp Cys
Gln Trp Cys Asn
Gln Trp Asn Cys
Gln Tyr Cys His
Gln Tyr His Cys
Ser Glu Glu Trp
Ser Glu Trp Glu
Ser Trp Glu Glu
Thr Asp Glu Trp
Thr Asp Trp Glu
Thr Glu Asp Trp
Thr Glu Trp Asp
Thr Trp Asp Glu
Thr Trp Glu Asp
Trp Cys Asn Gln
Trp Cys Gln Asn
Trp Asp Glu Thr
Trp Asp Thr Glu
Trp Glu Asp Thr
Trp Glu Glu Ser
Trp Glu Ser Glu
Trp Glu Thr Asp
Trp Asn Cys Gln
Trp Asn Gln Cys
Trp Gln Cys Asn
Trp Gln Asn Cys
Trp Ser Glu Glu
Trp Thr Asp Glu
Trp Thr Glu Asp
Tyr Cys His Gln
Tyr Cys Gln His
Tyr His Cys Gln
Tyr His Gln Cys
Tyr Gln Cys His
Tyr Gln His Cys
(2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid
N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid
C22H30F3N5O8 (549.2046376000001)
Ubrogepant
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CD - Calcitonin gene-related peptide (cgrp) antagonists C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
(1S)-1-[(2S)-butan-2-yl]-7-hydroxy-5-methyl-2,8,13-trioxo-1,2,8,13-tetrahydro-3aH-benzo[b][1,3]oxazolo[3,2-f]phenanthridin-12-yl 2,6-dideoxy-alpha-L-ribo-hexopyranoside
7-Methyl-1-phenyl-4-trimethylsilyl-7-azobicyclo(2,2,1)heptane-N,N-diphenyl-2,3,5,6-tetracarboxodiimido
C32H31N3O4Si (549.2083726000001)
ERK1/2 inhibitor 1
ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1/2 inhibitor, showing 60\% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively[1].
[(1r,2s,10r,12r,13s)-12-cyano-7,18-dimethoxy-6,17,21-trimethyl-5,8,16,19-tetraoxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl propanoate
(3s)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-3-(sec-butyl)-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
16-chloro-3-ethyl-1,4,7,11-tetrahydroxy-13-(1-hydroxyethyl)-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H32ClN5O7 (549.1990152000001)
(3r)-3-butyl-19-{[(2s,5r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
astin E
C25H32ClN5O7 (549.1990152000001)
{"Ingredient_id": "HBIN017205","Ingredient_name": "astin E","Alias": "astin e","Ingredient_formula": "C25H32ClN5O7","Ingredient_Smile": "CCC1C(=O)NC(C(=O)NC(CC(=O)NC(C(=O)N2C(CC=C2Cl)C(=O)N1)C(C)O)C3=CC=CC=C3)CO","Ingredient_weight": "550","OB_score": "26.33722415","CAS_id": "153125-16-7","SymMap_id": "SMIT11508;SMIT14404","TCMID_id": "1933","TCMSP_id": "MOL010457","TCM_ID_id": "6547","PubChem_id": "NA","DrugBank_id": "NA"}
astin h
C25H32ClN5O7 (549.1990152000001)
{"Ingredient_id": "HBIN017206","Ingredient_name": "astin h","Alias": "NA","Ingredient_formula": "C25H32ClN5O7","Ingredient_Smile": "NA","Ingredient_weight": "550","OB_score": "NA","CAS_id": "159396-51-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6546","PubChem_id": "NA","DrugBank_id": "NA"}
(3s,6s,9r,13s,18as)-16-chloro-13-ethyl-1,4,7,11-tetrahydroxy-3-[(1s)-1-hydroxyethyl]-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H32ClN5O7 (549.1990152000001)
n-[(2s,3r,4s,5r,6r)-2-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-3,5-dihydroxy-6-methyloxan-4-yl]-n-methylacetamide
(3s,6s,9r,13s,18as)-16-chloro-3-ethyl-1,4,7,11-tetrahydroxy-13-[(1s)-1-hydroxyethyl]-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H32ClN5O7 (549.1990152000001)
n-(2-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-3,5-dihydroxy-6-methyloxan-4-yl)-n-methylacetamide
(2s,3r,4r,5s,6r)-3-(acetyloxy)-2-hydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-n-methyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
(3s,6s)-3-[(2s)-butan-2-yl]-19-{[(2s,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
(2s,3s,4s,5s,6r)-3-(acetyloxy)-2-hydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-n-methyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
19-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-11-hydroxy-9-methyl-3-(sec-butyl)-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
(3s,6s)-3-[(2s)-butan-2-yl]-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
3-(acetyloxy)-2-hydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-n-methyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
(3s)-3-[(2s)-butan-2-yl]-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
14-(3,4-dimethoxyphenyl)-10,11-dihydroxy-8-methoxy-n,n-dimethyl-13-phenyl-4,6,15-trioxatetracyclo[7.6.0.0³,⁷.0¹⁰,¹⁴]pentadeca-1,3(7),8-triene-12-carboxamide
16-chloro-13-ethyl-1,4,7,11-tetrahydroxy-3-(1-hydroxyethyl)-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H32ClN5O7 (549.1990152000001)